Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

Stephen S. Hall Guest Contributor

  • Fabulous Science

    Telling a good story has become essential to today’s biotechnology enterprise. But truth still matters.

  • Botstein's Caveat

    Scientists have declared the human genome completely decoded. But a look back at the beginnings of their quest reveals how far we still have to go.

  • Pharma's Blockbuster Habit

    Genomics will make possible the kind of customization that undermines the drug industry’s blockbuster mentality. But can Big Pharma kick the habit?

  • Ducking the Virus

    Drug companies make millions on lifestyle potions. Is R&D on more vital therapies lagging?

  • Strategic Patience

    Bob Swanson, the founder of Genentech, embodied virtues that today’s venture capitalists are badly in need of.

  • A Death in Philadelphia

    An experimental gene-therapy treatment kills an eighteen-year-old volunteer in a clinical trial. Is this the final blow for a much-beleaguered technology?

  • This Is No Fish Story

    The tale of Centocor is the latest reminder that the road to biotech success is seldom straight. Despite the best business plans, something keeps getting in the way. It’s called biology.

  • Care for Steak TATA?

    Public rejection of “cloned” beef may seem like a knee-jerk reaction to a loaded work. But biotech has a problem that isn’t going away.

  • Missing the Story

    Something is seriously amiss when “experts” identifying the century’s greatest journalism overlook coverage of science and technology.


From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me